Prescription Price Gouging: A Need for Good Government or Good Corporate Citizens?

Prescription Price Gouging: A Need for Good Government or Good Corporate Citizens?

  • Case
  • Teaching Notes
Abstract

Sara, a research and development (R&D) manager at one of the top pharmaceutical companies in the U.S., was surprised to see her cousin Rachel, who lives in a neighboring state, featured on a news segment personalizing the impact that high prescription drug prices have on ordinary families. Rachel demonized the pharmaceutical industry for its excessive price increases on critical medicines that average families need. Rachel wants to see more government action to curtail price increases for prescription drugs, especially for critical, life-saving medicines. In her role, Sara has little impact on the pricing model her company uses for prescription drugs, but knows that most new drugs do not make it to market with about 1 in 5,000 drugs successfully completing clinical trials, FDA approval, and ...

You are not authorized to view Teaching Notes. Please contact your librarian for access or sign in to your existing instructor profile.
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles